MIKEL
TAINTA CUEZVA
![Foto de MIKEL](/img/nophoto.png)
![Foto de University College London](/img/noimage_org.png)
University College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de University College London (24)
2023
-
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia
Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777
-
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort
Cortex, Vol. 150, pp. 12-28
-
Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
Frontiers in Aging Neuroscience, Vol. 14
-
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999
2021
-
Differential early subcortical involvement in genetic FTD within the GENFI cohort
NeuroImage: Clinical, Vol. 30
-
Replication study of plasma proteins relating to Alzheimer's pathology
Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464
-
Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
Biomedicines, Vol. 9, Núm. 11
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
-
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort
Alzheimer's Research and Therapy, Vol. 13, Núm. 1
2020
-
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
The Lancet Neurology, Vol. 19, Núm. 2, pp. 145-156
-
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia
Brain Communications, Vol. 2, Núm. 2
-
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults
Journal of Alzheimer's disease : JAD, Vol. 76, Núm. 2, pp. 643-656
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
-
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 3
-
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort
Cortex, Vol. 133, pp. 384-398
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225